摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3beta,20S)-20-甲基-孕甾-5-烯-3,21-二醇3-乙酸酯21-对甲苯磺酰基 | 120664-97-3

中文名称
(3beta,20S)-20-甲基-孕甾-5-烯-3,21-二醇3-乙酸酯21-对甲苯磺酰基
中文别名
——
英文名称
3β-acetoxy-22-O-(p-toluenesulfonyl)-5-cholen-22-ol
英文别名
3β-acetoxy-22-toluenesolfonyloxy-23,24-bisnorchol-5-ene;3β-acetoxy-23,24-bisnor-chol-5-en-22-yl p-toluenesulfonate;3β-acetoxy-22-(toluene-4-sulfonyloxy)-23,24-dinor-chol-5-ene;3β-Acetoxy-22-(toluol-4-sulfonyloxy)-23,24-dinor-chol-5-en;(3beta,20S)-20-Methyl-pregn-5-ene-3,21-diol 3-Acetate 21-Tosyl;[(3S,8S,9S,10R,13S,14S,17R)-10,13-dimethyl-17-[(2S)-1-(4-methylphenyl)sulfonyloxypropan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
(3beta,20S)-20-甲基-孕甾-5-烯-3,21-二醇3-乙酸酯21-对甲苯磺酰基化学式
CAS
120664-97-3
化学式
C31H44O5S
mdl
——
分子量
528.753
InChiKey
YJIVKCVTWWRTED-CIMDZAPNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 溶解度:
    溶于二氯甲烷、乙醚、乙酸乙酯

计算性质

  • 辛醇/水分配系数(LogP):
    7.5
  • 重原子数:
    37
  • 可旋转键数:
    7
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    78
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Hayatsu, Pharmaceutical Bulletin, 1957, vol. 5, p. 452,457
    摘要:
    DOI:
  • 作为产物:
    描述:
    3β-acetoxy-23,24-dinorchol-5-en-22-oyl chloride吡啶 、 lithium tri-t-butoxyaluminum hydride 作用下, 以 四氢呋喃 为溶剂, 反应 21.0h, 生成 (3beta,20S)-20-甲基-孕甾-5-烯-3,21-二醇3-乙酸酯21-对甲苯磺酰基
    参考文献:
    名称:
    A mechanism-based fluorogenic probe for the cytochrome P-450 cholesterol side chain cleavage enzyme
    摘要:
    The rate-limiting step of steroid biosynthesis is the enzymatic conversion of cholesterol to pregnenolone by cytochrome P-450scc (side chain cleavage) located in the inner mitochondrial membrane of all steroid producing cells. We report here the synthesis and application of a fluorogenic probe which is a cholene-based steroid with a fluorogenic moiety (resorufin) strategically located at the site of side chain cleavage. Synthesis of the probe required four steps starting from 3-beta-acetoxy-22,23-bisnor-5-cholenic acid and resorufin. Reaction of the probe with P-450scc yields pregnenolone and the highly fluorescent resorufin, thus providing a sensitive fluorescent signal representative of enzyme activity. The fluorescence quantum yield of this probe is approximately 40-fold lower (phi = 0.006) than resorufin (phi = 0.23) and is essentially nonfluorescent at wavelengths used to excite resorufin. The utility of the probe is demonstrated biochemically by incubation with mitochondria known to contain the P-450scc enzyme, and its specificity for this enzyme is shown by regulation of the enzyme activity with inhibitors and through the use of a nonspecific substrate.
    DOI:
    10.1021/jo00018a036
点击查看最新优质反应信息

文献信息

  • Preparation of (25)- and (25)-26-functionalized steroids as tools for biosynthetic studies of cholic acids
    作者:V KHRIPACH、V ZHABINSKII、O KONSTANTINOVA、N KHRIPACH、A ANTONCHICK、A ANTONCHICK、B SCHNEIDER
    DOI:10.1016/j.steroids.2005.02.014
    日期:2005.7
    new synthesis of both epimeric forms of 26-cholestanoic acids and 26-alcohols containing a 3beta-hydroxy-Delta(5)- or a Delta(4)-3-keto-functionality in ring A is described starting from stigmasterol or (20S)-3beta-acetoxy-pregn-5-en-20-carboxylic acid. The obtained compounds are useful as standards for studies of cholic acids. Construction of the side chain was achieved by linkage of steroidal 23-iodides
    豆甾醇或 (20S) 开始,描述了在环 A 中含有 3β-羟基-Delta(5)-或 Delta(4)-3-酮基官能团的 26-胆甾烷酸和 26-醇的差向异构形式的新合成)-3β-乙酰氧基-pregn-5-en-20-羧酸。所得化合物可用作研究胆酸的标准品。侧链的构建是通过将甾体 23-化物连接到由 (2R)- 和 (2S)-3-羟基-2-甲基丙酸酯制备的砜来实现的。使用由 TEMPO 和漂白剂催化的亚氯酸钠,将中间体 26-醇氧化成相应的羧酸,确保保留 C-25 的立体化学和环状部分的官能团。
  • Preparation of transition-state analogues of sterol 24-methyl transferase as potential anti-parasitics
    作者:Silvia Orenes Lorente、Carmen Jimenez Jimenez、Ludovic Gros、Vanessa Yardley、Kate de Luca-Fradley、Simon L. Croft、Julio A. Urbina、Luis M. Ruiz-Perez、Dolores Gonzalez Pacanowska、Ian H. Gilbert
    DOI:10.1016/j.bmc.2005.06.012
    日期:2005.9
    There is an urgent need for new drugs to treat leishmaniasis and Chagas disease. One important drug target in these organisms is sterol biosynthesis. In these organisms the main endogenous sterols are ergosta- and stigmata-like compounds in contrast to the situation in mammals, which have cholesterol as the sole sterol. In this paper we discuss the design, synthesis and evaluation of potential transition state analogues of the enzyme Delta(24(25))-methyltransferase (24-SMT). This enzyme is essential for the biosynthesis of ergosterol, but not required for the biosynthesis of cholesterol. A series of compounds were successfully synthesised in which mimics of the S-adenosyl methionine co-factor were attached to the sterol nucleus. Compounds were evaluated against recombinant Leishmania major 24-SMT and the parasites L. donovani and Trypanosoma cruzi in vitro, causative organisms of leishmaniasis and Chagas disease, respectively. Some of the-compounds showed inhibition of the recombinant Leishmania major 24-SMT and induced growth inhibition of the parasites. Some compounds also showed anti-parasitic activity against L. donovani and T cruzi, but no inhibition of the enzyme. In addition, some of the compounds had anti-proliferative activity against the bloodstream forms of Trypanosoma brucei rhodesiense, which causes African trypanosomiasis. (c) 2005 Published by Elsevier Ltd.
查看更多

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B